Cargando…

HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells

Intrinsic or acquired resistance to hormone therapy is frequently reported in estrogen receptor positive (ER(+)) breast cancer patients. Even though dysregulations of histone deacetylases (HDACs) are known to promote cancer cells survival, the role of different HDACs in the induction of hormone ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Wen-Tsung, Tsai, Yu-Hsuan, Chen, Shang-Hung, Kuo, Ching-Wen, Kuo, Yao-Lung, Lee, Kuo-Ting, Chen, Wen-Chung, Wu, Pei Chih, Chuang, Chun-Yu, Cheng, Siao Muk, Lin, Chun-Hui, Leung, Euphemia Yee, Chang, Yung-Chieh, Cheung, Chun Hei Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736991/ https://www.ncbi.nlm.nih.gov/pubmed/29326587 http://dx.doi.org/10.3389/fphar.2017.00902

Ejemplares similares

Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells
por: Lee, Jane Ying-Chieh, et al.
Publicado: (2016)

Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2020)

BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells
por: Lin, Tzu-Yu, et al.
Publicado: (2019)

Survivin – biology and potential as a therapeutic target in oncology
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2013)

Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study
por: Lin, Kun-Yuan, et al.
Publicado: (2016)

miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis
por: Hsieh, Tsung-Hua, et al.
Publicado: (2014)

HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer
por: Lin, Ching-Ling, et al.
Publicado: (2019)

B1, a novel HDAC inhibitor, induces apoptosis through the regulation of STAT3 and NF-κB
por: Cheng, Meng-Hsuan, et al.
Publicado: (2017)

HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells
por: Wu, An-Chih, et al.
Publicado: (2022)

HDAC1 is Involved in Neuroinflammation and Blood-Brain Barrier Damage in Stroke Pathogenesis
por: Wang, Hao-Kuang, et al.
Publicado: (2023)

Treatment of Myopia with Atropine 0.125% Once Every Night Compared with Atropine 0.125% Every Other Night: A Pilot Study
por: Chen, Zi-Rong, et al.
Publicado: (2023)

Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells
por: Liu, Jiaqi, et al.
Publicado: (2016)

Histone deacetylase HDAC2 regulates microRNA‐125a expression in neuroblastoma
por: Liu, Denghui, et al.
Publicado: (2022)

Specific Control of Pancreatic Endocrine β- and δ-Cell Mass by Class IIa Histone Deacetylases HDAC4, HDAC5, and HDAC9
por: Lenoir, Olivia, et al.
Publicado: (2011)

The HDAC Inhibitor LBH589 Induces ERK-Dependent Prometaphase Arrest in Prostate Cancer via HDAC6 Inactivation and Down-Regulation
por: Chuang, Mei-Jen, et al.
Publicado: (2013)

Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
por: Seo, Jinwon, et al.
Publicado: (2014)

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
por: Huang, Renhong, et al.
Publicado: (2018)

Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
por: Fang, Wen-Feng, et al.
Publicado: (2018)

Prior alcohol use enhances vulnerability to compulsive cocaine self-administration by promoting degradation of HDAC4 and HDAC5
por: Griffin, Edmund A., et al.
Publicado: (2017)

Role of Phosphorylated HDAC4 in Stroke-Induced Angiogenesis
por: Liu, Juan, et al.
Publicado: (2017)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
por: Thomas, Elizabeth A.
Publicado: (2014)

Calreticulin nuclear translocalization alleviates CaM/CaMKII/CREB signaling pathway to enhance chemosensitivity in HDAC inhibitor-resistant hepatocellular carcinoma cells
por: Liu, Yi-Sheng, et al.
Publicado: (2022)

Insights Into the Function and Clinical Application of HDAC5 in Cancer Management
por: Yang, Jun, et al.
Publicado: (2021)

Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis
por: Lu, Chien-Yi, et al.
Publicado: (2017)

Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma
por: Que, Yi, et al.
Publicado: (2021)

HDAC8 Inhibitor WK2-16 Therapeutically Targets Lipopolysaccharide-Induced Mouse Model of Neuroinflammation and Microglial Activation
por: Lin, Fan-Li, et al.
Publicado: (2019)

HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
por: Yoon, Somy, et al.
Publicado: (2016)

HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells
por: Chen, Shu-Huey, et al.
Publicado: (2019)

Inhibition of Protein Phosphatase 1 Stimulates Noncanonical ER Stress eIF2α Activation to Enhance Fisetin-induced Chemosensitivity in HDAC Inhibitor-resistant Hepatocellular Carcinoma Cells
por: Liu, Yi-Sheng, et al.
Publicado: (2019)

Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn’s disease patients
por: Chervy, Mélissa, et al.
Publicado: (2022)

HDAC3 and HDAC8 are required for cilia assembly and elongation
por: Park, Seon-ah, et al.
Publicado: (2019)

Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
por: King, Jacob, et al.
Publicado: (2021)

HDAC5 inhibition attenuates ventricular remodeling and cardiac dysfunction
por: Zhu, Chenxi, et al.
Publicado: (2023)

Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2009)

HDAC-an important target for improving tumor radiotherapy resistance
por: Ling, Rui, et al.
Publicado: (2023)

Dihydrocoumarin, an HDAC Inhibitor, Increases DNA Damage Sensitivity by Inhibiting Rad52
por: Chen, Chin-Chuan, et al.
Publicado: (2017)

Development of a cancer cells self-activating and miR-125a-5p expressing poly-pharmacological nanodrug for cancer treatment
por: Chang, Yung-Chieh, et al.
Publicado: (2022)

MCM5 Aggravates the HDAC1-Mediated Malignant Progression of Lung Cancer
por: Zhang, Lin-lin, et al.
Publicado: (2021)

Histone Deacetylase HDAC4 Promotes Gastric Cancer SGC-7901 Cells Progression via p21 Repression
por: Kang, Zhen-Hua, et al.
Publicado: (2014)

Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines
por: Sixto-López, Yudibeth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4qn7bepsg72f50e34je93grtcs